How external quality controls are transforming molecular diagnostics
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges
In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1
Oxford researcher Nina Dimova pushes pixel-by-pixel calibration and clustering to unlock nanosecond precision in particle tracking and electron microscopy
Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026
The study showed the NFTriSolve four-component formula showed clear advantages over conventional single-ingredient and three-component formulations.
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Peer-reviewed findings published in the Journal of Alzheimer's Disease Reports show a 63% reduction in phosphorylated tau after a nine-week oral protocol
Clarkson University‑led study demonstrates light‑ and electricity‑driven approach for destroying PFAS under real‑world conditions
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies
IMAAVY is designed to target the underlying cause of warm autoimmune hemolytic anemia by reducing circulating immunoglobulin G, including autoantibodies, while preserving critical immune functions
Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets
Expanded CFTR variant coverage designed to align with updated professional recommendations
After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories